NCT05292833Completed
Study on Adherence to a Mediterranean Diet in a Population of Patients With Type 2 Diabetes
Study on Adherence to a Mediterranean Diet in a Population of Patients With Type 2 Diabetes Diet-Med
Source: ClinicalTrials.gov · Last updated 23 Jan 2026
Brief summary (registry, in English)
In randomized clinical studies, the mediterranean diet has demonstrated beneficial effects on glucose and lipids levels, on body composition, on waist to hip ratio, especially in patients with type 2 diabetes. Consequently, the meditteranean diet is now recommended by experts in cardiology, nutrition and diabetology. However, many of these publications have been generated in populations living around the Mediterranean Basin. Thus, it is not sure that this diet can be used by people living outside this geographic area. We aimed to study the capacity of consecutive patients admitted in diabetology to follow the mediterranean diet recommandations during 12 months. The adherence will be studied in the real life in order to identify all limitations to follow this diet. Therefore, this study may help to find solutions to reinforce adherence to this diet.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 14 Mar 2022
- Start date
- 6 Jul 2023
- Primary completion date
- 24 Jan 2024
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Diseases
- Type 2 diabetes
- NCT number
- NCT05292833
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 6 Jul 2023 to the primary completion date, 24 Jan 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with current or recent infections (\<10 days).
- Patient with unstable neoplastic (with the exception of carcinoma in situ of the cervix or cutaneous epithelioma), hematological, psychiatric (with the exception of eating disorders (ED)).
Other
- Pregnant or breastfeeding patient.
- Person under legal protection.
Who the study is looking for
- Patient over 18 years old.
- Patient with type 2 diabetes regardless of the hypoglycaemic treatments used and their HbA1c level.
- Patient referred to the Diabetology day hospital of the CHU Pitié-Salpêtrière and Nutrition of the HEGP for assessment of diabetes and/or for obesity assessment and dietary education as part of routine care.
- Patient accepting the constraints of the protocol after explanation of it and not opposing to participate in it.
- Patient benefiting from or entitled to health insurance coverage outside of the AME.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Européen Georges Pompidou - Diabétologie Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Diabetology Department - Pitié-Salpêtrière Hospital Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Pitié Salpêtrière - Nutrition Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.